Serum CA 125 in acute pelvic inflammatory disease

1989 ◽  
Vol 96 (10) ◽  
pp. 1246-1246
Author(s):  
L.C. Fuith
Keyword(s):  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
Ca 125 ◽  
Acute Pelvic Inflammatory Disease

Serum CA-125 in the diagnosis of acute pelvic inflammatory disease

1994 ◽  
Vol 44 (1) ◽  
pp. 53-57 ◽  
Author(s):  
J. Mozas ◽  
J.A. Castilla ◽  
P. Jimena ◽  
T. Gil ◽  
M. Acebal ◽  
...  
Keyword(s):  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
Ca 125 ◽  
Acute Pelvic Inflammatory Disease

Serum CA 125 in acute pelvic inflammatory disease

1989 ◽  
Vol 96 (5) ◽  
pp. 574-579 ◽  
Author(s):  
J. PAAVONEN ◽  
A. MIETTINEN ◽  
P. K. HEINONEN ◽  
R-K. AARAN ◽  
K. TEISALA ◽  
...  
Keyword(s):  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
Ca 125 ◽  
Acute Pelvic Inflammatory Disease

CA 125 in Benign Gynecological Conditions

1998 ◽  
Vol 13 (4) ◽  
pp. 231-237 ◽  
Author(s):  
H. Meden ◽  
A. Fattahi-Meibodi
Keyword(s):  
Tumor Marker ◽  
Ectopic Pregnancy ◽  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
Cirrhosis Of The Liver ◽  
Ca 125 ◽  
Ovarian Cysts ◽  
Gynecological Tumors ◽  
Ovarian Abscess

The tumor marker CA 125 was initially thought to be specific for ovarian malignancies. Subsequently it was found to be raised in a variety of benign conditions, including pregnancy, pelvic inflammatory disease, tuberculosis and cirrhosis of the liver. With respect to gynecological tumors, CA 125 may be elevated in benign ovarian cysts, tubo-ovarian abscess, endometriosis, hyperstimulation syndrome, ectopic pregnancy and fibroids. These results demonstrate that CA 125 is a marker of non-specific peritoneal conditions.

Sign in / Sign up

Export Citation Format

Share Document